subscribeSubscribe
Changzhou`s Generic Ticagrelor Receives Approval in the U.S.

Changzhou`s Generic Ticagrelor Receives Approval in the U.S.
FDA
07 Jun 2023
Share Share
Annora`s Generic Ticagrelor Receives Approval in the U.S.

Annora`s Generic Ticagrelor Receives Approval in the U.S.
FDA
02 Jun 2023
Share Share
Changzhou`s Generic Ticagrelor Receives Approval in the U.S.

Changzhou`s Generic Ticagrelor Receives Approval in the U.S.
FDA
12 Dec 2022
Share Share
PhaseBio shows Brilinta reversal agent can work in an emergency

PhaseBio shows Brilinta reversal agent can work in an emergency
Alex Keown BIOSPACE
16 Nov 2021
Share Share
PhaseBio`s Brilinta reversal agent wins midstage test

PhaseBio`s Brilinta reversal agent wins midstage test
Annalee Armstrong FIERCEBIOTECH
03 Nov 2021
Share Share
Sobi drug cuts death risk; heart drugs may help prevent COVID-19 blood clots

Sobi drug cuts death risk; heart drugs may help prevent COVID-19 blood clots
REUTERS
10 Sep 2021
Share Share
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A

PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A
BUSINESSWIRE
16 Jun 2021
Share Share
PhaseBio taps a manufacturing partner for Brilinta-reversing med

PhaseBio taps a manufacturing partner for Brilinta-reversing med
Amirah Al Idrus FIERCEBIOTECH
11 Mar 2021
Share Share
Ticagrelor Nonsuperior to Clopidogrel for Prevention of MI After Elective

Ticagrelor Nonsuperior to Clopidogrel for Prevention of MI After Elective
Walter Alexander FIRSTWORDPHARMA
17 Nov 2020
Share Share
Ticagrelor was not superior to clopidogrel to reduce heart attack risk

Ticagrelor was not superior to clopidogrel to reduce heart attack risk
HEART
16 Nov 2020
Share Share